Intellia Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
50%
€38.49
Target price
31.03.26
€50.00
Performance (%)
-68.33%
End price
14.12.24
€12.19
Summary
This prediction ended on 14.12.24 with a price of €12.19. Massive losses of -68.33% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -6.447% | -6.447% | 6.454% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
According to BiotechBee what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Buy mit Kursziel 50,0